Bilal A. Mateen, Vaishnavi Menon, Ambrose Agweyu, Robert Korom, Elizabeth Omoluabi, David McAfee, Natnael Shimelash, Samuel Rutunda, Crystal Rugege, Gwydion Williams, Mira Emmanuel-Fabula, Alastair K. Denniston, Xiaoxuan Liu, Melissa Miles
{"title":"法学硕士支持的非洲初级卫生保健临床决策试验","authors":"Bilal A. Mateen, Vaishnavi Menon, Ambrose Agweyu, Robert Korom, Elizabeth Omoluabi, David McAfee, Natnael Shimelash, Samuel Rutunda, Crystal Rugege, Gwydion Williams, Mira Emmanuel-Fabula, Alastair K. Denniston, Xiaoxuan Liu, Melissa Miles","doi":"10.1038/s41591-025-03815-3","DOIUrl":null,"url":null,"abstract":"<p>Primary healthcare systems in sub-Saharan Africa face considerable challenges, particularly constrained clinical capacity<sup>1</sup> and variable quality-of-care delivery<sup>2</sup>. Large language models (LLMs) represent a potentially transformative solution for clinical decision-making. Some LLMs have shown that they can recall clinical knowledge at expert level<sup>3</sup> and can diagnose clinical vignettes (in simulated settings) more accurately than clinicians<sup>4</sup>. However, despite the fact that LLMs have shown promise, there is a striking lack of real-world evidence for their safe and effective use in clinical settings in Africa. Thus far, only handful of randomized trials of artificial intelligence (AI) for health (and none for generative AI tools) have been conducted on the continent<sup>5</sup>.</p><p>In Kenya, a pragmatic randomized controlled trial (RCT) has been embedded into routine care delivery undertaken at 16 of Penda Health’s clinics<sup>6</sup>, a Nairobi-based social enterprise that provides primary care services across all socioeconomic groups, from state social insurance recipients to privately insured and out-of-pocket payers. The trial aims to enroll 9,000 patients. The solution being trialed is an LLM-based ‘co-pilot’ feature that has been integrated directly into Penda’s electronic medical record system. Clinicians randomly assigned to the intervention arm receive automated, real-time suggestions for diagnosis, treatment planning and lab interpretation during patient consultations.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"76 1","pages":""},"PeriodicalIF":58.7000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trials for LLM-supported clinical decisions in African primary healthcare\",\"authors\":\"Bilal A. Mateen, Vaishnavi Menon, Ambrose Agweyu, Robert Korom, Elizabeth Omoluabi, David McAfee, Natnael Shimelash, Samuel Rutunda, Crystal Rugege, Gwydion Williams, Mira Emmanuel-Fabula, Alastair K. Denniston, Xiaoxuan Liu, Melissa Miles\",\"doi\":\"10.1038/s41591-025-03815-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Primary healthcare systems in sub-Saharan Africa face considerable challenges, particularly constrained clinical capacity<sup>1</sup> and variable quality-of-care delivery<sup>2</sup>. Large language models (LLMs) represent a potentially transformative solution for clinical decision-making. Some LLMs have shown that they can recall clinical knowledge at expert level<sup>3</sup> and can diagnose clinical vignettes (in simulated settings) more accurately than clinicians<sup>4</sup>. However, despite the fact that LLMs have shown promise, there is a striking lack of real-world evidence for their safe and effective use in clinical settings in Africa. Thus far, only handful of randomized trials of artificial intelligence (AI) for health (and none for generative AI tools) have been conducted on the continent<sup>5</sup>.</p><p>In Kenya, a pragmatic randomized controlled trial (RCT) has been embedded into routine care delivery undertaken at 16 of Penda Health’s clinics<sup>6</sup>, a Nairobi-based social enterprise that provides primary care services across all socioeconomic groups, from state social insurance recipients to privately insured and out-of-pocket payers. The trial aims to enroll 9,000 patients. The solution being trialed is an LLM-based ‘co-pilot’ feature that has been integrated directly into Penda’s electronic medical record system. Clinicians randomly assigned to the intervention arm receive automated, real-time suggestions for diagnosis, treatment planning and lab interpretation during patient consultations.</p>\",\"PeriodicalId\":19037,\"journal\":{\"name\":\"Nature Medicine\",\"volume\":\"76 1\",\"pages\":\"\"},\"PeriodicalIF\":58.7000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41591-025-03815-3\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03815-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Trials for LLM-supported clinical decisions in African primary healthcare
Primary healthcare systems in sub-Saharan Africa face considerable challenges, particularly constrained clinical capacity1 and variable quality-of-care delivery2. Large language models (LLMs) represent a potentially transformative solution for clinical decision-making. Some LLMs have shown that they can recall clinical knowledge at expert level3 and can diagnose clinical vignettes (in simulated settings) more accurately than clinicians4. However, despite the fact that LLMs have shown promise, there is a striking lack of real-world evidence for their safe and effective use in clinical settings in Africa. Thus far, only handful of randomized trials of artificial intelligence (AI) for health (and none for generative AI tools) have been conducted on the continent5.
In Kenya, a pragmatic randomized controlled trial (RCT) has been embedded into routine care delivery undertaken at 16 of Penda Health’s clinics6, a Nairobi-based social enterprise that provides primary care services across all socioeconomic groups, from state social insurance recipients to privately insured and out-of-pocket payers. The trial aims to enroll 9,000 patients. The solution being trialed is an LLM-based ‘co-pilot’ feature that has been integrated directly into Penda’s electronic medical record system. Clinicians randomly assigned to the intervention arm receive automated, real-time suggestions for diagnosis, treatment planning and lab interpretation during patient consultations.
期刊介绍:
Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors.
Nature Medicine consider all types of clinical research, including:
-Case-reports and small case series
-Clinical trials, whether phase 1, 2, 3 or 4
-Observational studies
-Meta-analyses
-Biomarker studies
-Public and global health studies
Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.